20th Annual Healthcare Summit The Future of Innovation, Personalized Medicine and Genomics October 26-27, 2020, Vancouver, BC

General Information

*Please note the date change – Event postponed from June 22-23 due to COVID-19*

*Please note the summit is now fully virtual*

Innovation in the Time of COVID

Be part of an exclusive Summit with top thought leaders and policy decision-makers in healthcare. The 20th Annual Healthcare Summit is a national forum to discuss the transformation of personalized medicine, genomics and technological innovation in today’s rapidly evolving digital health economy. It is attended by healthcare officials, senior policy makers, academia and the private sector.

This year’s summit will be a digital first experience on our customized virtual platform with an immersive feel and features that will engage our delegates from start to finish. We will deliver our virtual summit from a professional TV studio with a full production team and there will no longer be a hybrid option due to COVID.

This summit brings together subject matter experts in the fields of digital health technology, personalized medicine, innovative healthcare delivery and treatments. They will share case studies, cutting edge knowledge and policy, programs, research and technologies aimed at fostering successful collaboration within shared services and the healthcare industry. The summit also provides sponsors the opportunity to showcase their newest products, services and latest innovations.

Target Audience

  • Federal, provincial and regional healthcare officials
  • Senior policy makers
  • Intelligence and technology officials
  • Academics
  • Healthcare professionals

Summit Rates

Virtual Registration**
Public Sector $350.00 CAD (plus GST)
Private Sector $350.00 CAD (plus GST)

**If purchasing 10+ virtual passes please contact us regarding a group rate and group payment.

If you are a post-secondary student please inquire about our student rate.

Registration Fees Include

  • All keynotes and panel sessions
  • Access to virtual platform
  • Access to virtual exhibition
  • Virtual conference bag

Social Media

Stay connected and engaged in the conversation leading up to and during the summit by following along on Twitter. Use the event hashtag to follow others who are already posting, and include it in your tweets to add to the existing discussions. The hashtags for this year’s summit are #HCS20 and #healthsumm and our NEW twitter handle is @HLTHCARESUMM. We would appreciate you sharing your voice with our other followers.


Keynote Speakers

Dr. Ken Abrams

Managing Director and Chief Medical Officer, Deloitte

Mary Ackenhusen

Senior Executive in Residence, Ministry of Health, Province of BC

Dr. Pieter Cullis

Professor, Biochemistry and Molecular Biology, UBC

Bogi Eliasen

Director of Health, Copenhagen Institute for Future Studies

Dr. Catalina Lopez-Correa

Executive Director, CanCOGeN

Shelagh Maloney

Executive Vice President, Engagement and Marketing, Canada Health Infoway

Dr. Helia Mohammadi

Chief Data Scientist – National Healthcare, Microsoft Canada

Dr. Shez Partovi

Worldwide Lead for Healthcare, Life Sciences, Genomics, Medical Devices, Agriculture, Amazon Web Services

Jennifer Radin

Principal and Chief Innovation Officer, Life Sciences & Health Care, Deloitte

Juggy Sihota

Vice President, Consumer Health, TELUS

Dr. Verna Yiu

President & CEO, Alberta Health Services


Dianne Balon

Senior Vice President, Government, Alberta Blue Cross

Dr. Francois Belanger

Vice President, Quality & Chief Medical Officer, Alberta Health Services

Dr. Nadine Caron

Cancer and Wellness Chair, First Nations Health Authority

Dr. Jonathan Choy

Provincial Medical Director, Virtual Health, Alberta Health Services

Dr. Pieter Cullis

Professor, Biochemistry and Molecular Biology, UBC

Fiona Dalton

President & CEO, Providence Health

Dr. Federica Di Palma

Chief Scientific Officer & Vice President, Sectors, Genome BC

Joyce Drohan

Partner, BC Leader for Omnia AI, Deloitte

Dr. Robert Fraser

President and CEO, Molecular You

Neil Fraser

President, Medtronic Canada

Dr. John Glaser

Executive-in-Residence, Harvard Medical School Executive Education

Robin Gould-Soil

Consultant; Former Chief Privacy Officer, HSBC

Dr. Alexandra Greenhill

CEO and Chief Medical Officer, Careteam

Dr. Scott Halperin

Director, Canadian Center for Vaccinology (CCfV)

Dr. Bettina Hamelin

President and CEO, Ontario Genomics

David Helliwell

Co-Founder & Executive Board Chair, Thrive Health

Dr. Kendall Ho

Emergency Physician; Professor, UBC Faculty of Medicine, Department of Emergency Medicine

Megan Hunt

Executive Director of Primary Care & eHealth, First Nations Health Authority

Dr. David Huntsman

Chief Medical Officer, Canexia Health

Wendy Hurlburt

President and CEO, LifeSciences BC

Dr. Deepak Kaura

Chief Medical Officer, 1QBit

Jim Kean

VP, Infrastructure and Operations, Cambia Health Solutions

Dr. Douglas Kingsford

Provincial Chief Medical Information Officer, Ministry of Health, Province of BC

Patricia Kosseim

Information and Privacy Commissioner of Ontario

Aaron Leibtag

CEO, Pentavere

Dr. Catalina Lopez-Correa

Executive Director, CanCOGeN

Dr. Alan Low

Clinical Associate Professor, Faculty of Pharmaceutical Sciences, UBC; Exec. Director, MedAccess BC; Primary Care Pharmacist & Pharmacy Lead, BioPro Biologics Pharmacy

Dr. James Lu

Co-Founder & Chief Scientific Officer, Helix

Chad Mitchell

Assistant Deputy Minister, Pharmaceutical and Supplementary Benefits, Alberta Health

Sue Paish

CEO, Canada’s Digital Technology Supercluster

Dr. Gary Pansegrau

Senior Executive Director, Clinical Programs and Policy, BC Cancer

Dr. Matt Parker

Health Sector Lead, AltaML

Ted Patterson

Assistant Deputy Minister, Primary Care Division, Ministry of Health, Province of BC

Dr. John Pawlovich

Program Coordinator, Rural Education Action Plan; Medical Director, Carrier Sekani Family Services; Telehealth Sector Lead, RCCbc

Dr. Dean Regier

Senior Scientist, Cancer Control Research, BC Cancer

Dr. Jim Russell

Professor, Department of Medicine, UBC

Fanny Sie

Strategic Healthcare Partner – AI and Digital Health, Roche

Christina Sit

Program Manager, Lung Cancer Canada

Pamela Snively

VP, Chief Data & Trust Officer, TELUS

Shawn Surber

Vice President, Technical Solutions Engineering, Tanium

Helen Trifonopoulos

Vice President, Health Policy and Patient Access, Oncology, Novartis

Howard Waldner

Former President and CEO, Island Health; Adjunct Professor, School of Population and Public Health, UBC

Nancy White

CEO, Inagene Diagnostics

Donna Wilson

Executive Vice President, Provincial Health Services Authority

Troy Yoder

Global Healthcare Leader, Public Sector, Cisco
Print Agenda

*Invited Speaker

Click on the date of the agenda you would like to view. Please note the timezone listed on the agenda.

Monday, October 26, 2020

8:45am - 8:55am PST

Call to Conference

8:55am - 10:25am PST

Opening Keynote Series: Innovation in the Time of COVID

This panel will look into the insights on how a pandemic created a crucible of change. Throwing off the shackles of inertia & forging rapid innovation and creating the basis for transformation of the healthcare system.

10:25am - 10:40am PST Virtual Lobby

Morning Break

10:40am - 11:25am PST

Keynote Address by Roche

The emerging paradigm of personalized health and why we need it. Explore megatrends in healthcare as a frame to discuss the future of health. Take a Global and Canadian view on related impacts on the public, private, and the individual person. Describe technology, its application and what is needed to enable personalized health for different stakeholders.

11:30am - 12:45pm PST

Panel: Virtual Care in BC: System Innovation in the Time of COVID and Beyond

Virtual care/telehealth has talked about as the next wave of healthcare for a decade or more, with examples and pilot studies as to how different virtual care approaches can be used to improve quality and access of care. However, uptake of virtual care in the main healthcare systems across Canada and globally has been relatively low. COVID rapidly transformed how virtual care is embraced by health professionals and health systems. This session is to explore how virtual care is taken up as a health system innovation in establishing a range of complementary lines of services to support patient care and peer-to-peer health professional support. The objectives of this session for participants are:
·To discuss the rationale of each of the virtual care line of service and how they complement each other for a system of virtual care
·To understand the relationship-based planning and genesis of this system using the pentagram + approach
·To explore the future of integration of this virtual care system into the fabric of holistic, longitudinal primary care

12:45pm - 1:50pm PST Virtual Lobby

Lunch Break - Please Check out our Virtual Exhibitions!

1:50pm - 2:25pm PST

Keynote Address by AWS: Thinking Big: How AWS Cultivates Innovation in Healthcare

From benchtop to bedside, AWS helps healthcare organizations innovate faster to improve patient outcomes and improve the provision of value-based care. AWS has collaborated with numerous public health organizations around the globe to support their efforts to cope with the ripple effect of COVID-19. This includes providing customers in the most affected regions with technical support and AWS Promotional Credit to help cover costs of initiatives related to COVID-19 responses.

Since the pandemic began, health system customers have and are continuing to ask for increased support in areas including cloud adoption, data interoperability and machine learning. Listen to Dr. Shez Partovi, AWS Worldwide Lead: Healthcare, Life Sciences, Genomics, Medical Devices & Agriculture shares real Canadian and global customer stories that demonstrate how AWS supported the rapid adoption and implementation of technologies ranging from telehealth to interoperability solutions in wake of the COVID-19 pandemic.

Dr. Partovi will provide examples of AWS helping organizations quickly scale their technology and infrastructure to help maintain clinical and operational continuity during this unprecedented time for our global healthcare system – allowing for innovation, provision and continuity of essential healthcare services to patients and citizens during this critical time.

2:30pm - 3:45pm PST

Concurrent Panel A: Precision Oncology in the Age of COVID and Beyond

2:30pm - 3:45pm PST

Concurrent Panel B: COVID Impacts: Public and Private Sector View

How has the pandemic provided the opportunity for accelerated innovation, more collaboration and faster and more focused implementation?

3:45pm- 4:05pm PST Virtual Lobby

Afternoon Break

4:05pm - 4:35pm PST

Keynote Address by Deloitte: Caring for Caregivers – Using Workforce Strategy Levers to Support Mental Well-being

Caregivers are facing unparalleled levels of stress and responsibility in light of COVID-19.

This point of view details how COVID-19 has amplified pre-existing challenges of burnout, distress, and maintaining well-being, and provides a list of proactive approaches that health care organizations can leverage to help better support caregiver well-being.

These interventions range from immediate operational measures such as mental distress screenings and support services, to a much longer-term systemic activation of new norms and culture. Especially now, it is critical that health care leaders provide caregivers an infrastructure of support that prioritizes caregiver well-being now and in the future.

4:40pm - 5:10pm PST

Keynote Address by TELUS: Evolving Technologies to Meet Evolving Needs: Adaptability and Innovation in the COVID-19 Era

The pandemic has forced us to rethink our approach to healthcare in Canada. Policy and delivery shifted in a matter of weeks with members of the healthcare community -- from frontline workers to researchers and engineers and business leaders -- coming together to meet the unique and rapidly evolving care needs of Canadian families and communities. Keynote speaker, Juggy Sihota, Vice President of Consumer Health at TELUS, shares her perspective on the importance of adaptability in times of crisis, the opportunities for innovation and how these shifts will impact the ways in which we experience healthcare in the future.

5:10pm - 5:15pm PST

Closing Remarks

Tuesday, October 27, 2020

8:25am - 8:30am PST

Administrative Announcements

8:30am - 9:05am PST

Keynote Address by Microsoft: AI in Canadian Healthcare: Trends, Challenges & Case Studies

The COVID-19 pandemic has impacted nearly every aspect of people’s lives and every aspect of the healthcare system. It’s preventing healthcare delivery practices from operating at normal business levels, it’s disrupting patient access to high-quality medical care, and it’s forcing everyone to think about how to continue pushing forward in new and different ways. Join Microsoft as we share case studies in accelerated innovation in Canadian healthcare, broader challenges which are being addressed by artificial intelligence, and our vision in empowering every healthcare provider with better experiences, better insights and better care.

9:10am - 10:25am PST

Concurrent Panel A: Will COVID-19 Speed Up or Slow Down the Transformation to Value Based Healthcare?

Across the globe, healthcare costs have continued to climb to the point of threatening other parts of the economy, even before the COVID-19 pandemic. Close to 25% of total healthcare spending can be considered wasteful, highlighting the need to align payment with value delivered. Healthcare providers and payers are working together to implement patient-centric data-driven care and payment models that emphasize reducing costs and improving outcomes that matter to a patient.

The panel will explore how the crisis has increased adoption of virtual care technologies, interoperable data platforms and outcome measurements and whether this will be the accelerator needed for broad adoption and long-lasting implementation of value-based healthcare.

10:25am - 10:45am PST Virtual Lobby

Morning Break

10:45am – 12:00pm PST

Concurrent Panel A: COVID-19 and the Acceleration of AI Implementation in Healthcare

As healthcare systems around the world grapple with COVID-19, technological innovation and ingenuity are being harnessed at an unparalleled pace. Artificial Intelligence (AI) and Machine Learning (ML) are playing key roles in better understanding and addressing COVID-19 including scaling communications, tracking the virus, and accelerating research and treatments. The panel will present how they have employed AI/ ML technologies to address this global crisis and discuss their challenges, successes and the potential for lasting benefits these technologies can deliver to patients moving forward.

10:45am – 12:00pm PST

Concurrent Panel B: Testing and Vaccine Development

This panel will shed some insights and ‘learnings’ from the testing issue. This has opened up both opportunities for collaboration between public and private sector, innovation and regrettably, some rather large gaps in capacity, collaboration and speed to action.

12:00 - 1:05pm PST Virtual Lobby

Lunch Break - Please Check out our Virtual Exhibitions!

1:05pm –1:40pm PST

Keynote Address: Personalized Medicine and Personalized Medicines: The Impact on COVID-19

Personalized medicine or precision health uses biomarkers to diagnose disease and match therapy more accurately to disease. However, personalized medicine also includes the development of new medicines that are precisely designed for the particular individual they are administered to. Examples include medicines that are designed to treat rare hereditary diseases or are precisely targeted to diseased tissues in the body. BC is leading the way both to develop precise diagnostics using multi-Omic analyses and also to develop new therapeutics to treat diseases more effectively using nanomedicine technology. These approaches are having a major impact in many areas, including diagnosing and treating COVID-19. In particular, I will outline how discoveries made here in BC have led to the development of a highly potent COVID-19 vaccine that has completed Phase 3 clinical trials and is about to be distributed globally by Pfizer.

1:45pm – 3:00pm PST

Panel: COVID-19: The Case for and Barriers to Accessing and Sharing Health Data

The COVID-19 crisis highlighted several challenges beginning with the lack of access to current reliable data to inform physicians of treatment strategies that guide policymakers followed by the pressing need for more timely and effective data sharing along without obstacles. It is time for an open discussion about what the barriers are and how we can overcome them in a manner that addresses the full scope of citizens’ concerns.

3:00pm – 3:20pm PST Virtual Lobby

Afternoon Break

3:20pm – 4:50pm PST

Panel: The Inflection Point in Healthcare - Where Do We Go from Here?

The Pandemic has provoked the healthcare system and, in some areas, exposed its vulnerabilities. We have responded with accelerated use of digital tools and digital modalities to prevent disease spread, treat those affected and preserve life. We now recognize some of the major weaknesses in the healthcare chain that were not fully exposed. We need to leverage all of our creativity and ingenuity to further promote development and uptake of innovative approach to healthcare and use of data. The panelists will pull together some of the key points from the summit and inspire you to innovate, collaborate, and generate solutions.

4:50pm - 5:00pm PST

Closing Remarks & Announcements

Title Sponsor

Diamond Sponsors

Platinum Sponsors

Gold Sponsors

Summit Sponsors & Exhibitors

Summit Partners